by Arte de invertir | 05/04/2025 10:34 AM | NVDA
🛡️ While Nvidia's essential microchips for AI are expected to be exempt from tariffs, insulating it directly from import duties, the stock has still declined significantly.
📉 The decline is attributed partly to profit-taking after a strong run and broader market panic, but also reflects concerns about the sustainability of massive AI investments by its clients.
❓ A potential recession triggered or exacerbated by tariffs could lead companies to cut back on AI spending, impacting Nvidia's future growth prospects despite its current valuation appearing reasonable (around 20x earnings).
Read more!
by Arte de invertir | 05/04/2025 10:34 AM | V
🌐 Visa's business model, processing digital transactions and taking a percentage, is largely insulated from physical goods tariffs and has proven resilient even in economic downturns like 2008.
📈 The company boasts an extraordinarily high gross margin (98%), indicating minimal direct costs susceptible to tariff impacts and significant pricing power.
🛡️ While not entirely immune to a broader economic slowdown affecting consumer spending, Visa's core operations are less directly threatened by tariffs compared to companies reliant on physical imports, making it a relative safe haven.
Read more!
by Arte de invertir | 23/03/2025 11:26 AM | MPW
🏥 Medical Properties Trust (MPT) owns healthcare properties like hospitals and clinics, offering a stable and predictable income stream due to long-term leases (average 10 years).
📉 MPT has a low debt leverage of 25%, significantly lower than the industry average of around 50%, indicating strong financial health and lower risk.
💰 The company is currently trading at 11 times Funds From Operations (FFO), which is below the typical valuation for healthcare REITs, and offers a dividend yield of 6-7%.
Read more!
by Arte de invertir | 23/03/2025 11:26 AM | TITC
🏗️ Titan Cement International is strategically separating its U.S. division, which is expected to unlock significant value for shareholders due to higher valuations in the U.S. market.
📈 The U.S. division alone is valued significantly higher than Titan Cement's entire market capitalization, indicating a substantial undervaluation of the company.
🇺🇸 The spin-off and listing of the U.S. division on a U.S. exchange could lead to a re-rating of the stock, attracting more investors and increasing liquidity.
Read more!
by Arte de invertir | 23/03/2025 11:26 AM | NA9
📉 Nagarro's stock price recently dropped due to concerns about Accenture's comments on government spending cuts and a major shareholder leaving the supervisory board, but these factors have minimal impact on Nagarro's core business.
💼 The major shareholder who left the board is at an advanced age and is stepping back from commitments, and he has actually increased his stake in the company from 21% to 24%.
💰 Nagarro is currently trading at a low valuation (around 11-12 times earnings) despite its solid growth prospects and strong financial position.
Read more!
